Prestige Consumer Healthcare (PBH) Other Non Operating Income (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Other Non Operating Income of -$10.0 million in Q4 2025, down 1897.01% quarter-over-quarter from -$501000.0 in Q3 2025, and down 2734.28% on a YoY basis from $379800.5 in Q4 2024.
Prestige Consumer Healthcare (PBH) Other Non Operating Income (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Other Non Operating Income history runs 15 years deep, the most recent figure standing at -$10.0 million for Q4 2025.
- In Q4 2025, Other Non Operating Income fell 2734.28% year-over-year to -$10.0 million; the TTM figure through Dec 2025 stood at -$14.0 million (down 1616.81% YoY), while the FY2025 annual figure was -$5.0 million, down 755.29% from the prior year.
- Other Non Operating Income was -$10.0 million for Q4 2025 at Prestige Consumer Healthcare, down from -$501000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.4 million in Q1 2021 to a low of -$10.0 million in Q4 2025.
- Historically, Other Non Operating Income has averaged -$944947.4 across 5 years, with a median of -$487000.0 in 2022.
- The sharpest annual moves came in 2021 and 2025: Other Non Operating Income soared 1150.0% in 2021, then plunged 2734.28% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at -$2.1 million in 2021, then soared by 45.81% to -$1.2 million in 2022, then jumped by 40.7% to -$682000.0 in 2023, then soared by 48.24% to -$353000.0 in 2024, then slumped by 2734.28% to -$10.0 million in 2025.
- The last three Other Non Operating Income figures came in at -$10.0 million (Q4 2025), -$501000.0 (Q3 2025), and $224000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.01 Mn |
| Sep 30, 2025 | -501,000.00 |
| Jun 30, 2025 | 224,000.00 |
| Mar 31, 2025 | -3.71 Mn |
| Dec 31, 2024 | -353,000.00 |
| Sep 30, 2024 | -395,000.00 |
| Jun 30, 2024 | -496,000.00 |
| Mar 31, 2024 | 429,000.00 |
| Dec 31, 2023 | -682,000.00 |
| Sep 30, 2023 | -229,000.00 |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 451,000.00 |
| Dec 31, 2022 | -1.15 Mn |
| Sep 30, 2022 | -812,000.00 |
| Jun 30, 2022 | -825,000.00 |
| Mar 31, 2022 | -487,000.00 |
| Sep 30, 2021 | -2.12 Mn |
| Jun 30, 2021 | 105,000.00 |
| Mar 31, 2021 | 1.37 Mn |
| Dec 31, 2020 | 371,000.00 |